Thomas Kahan

About me
Publications
Public outreach and news

About me

Senior consultant in cardiolgy at the Department of cardiology, Danderyd
University Hospital
MD at Karolinska Institutet, PhD in pharmacology at Karolinska Institutet.
Profssor in medicine. Board certified specialist in internal medicine and
caridolgy, working as clinical cardiolgist.

Research

My main research interests are related to neurohormonal mechanisms in the
control of blood pressure and cardiac function, with a focus on structural
myocardial and vascular changes in hypertension, hypertesive heart disease,
the transition from hypertension to heart failure, and on neuroendocrine
regulatory mechanisms in heart failure. In particular, we study effects of
the sympathetic nervous system and the renin-angiotensin-aldosterone system
in this context. Other areas of interest are cardiovacular risk assesment and
prevention, and health economics and implementation of treatment.

Articles

Article: BLOOD PRESSURE. 2025;34(1):2487583
Cost-effectiveness analysis of radiofrequency renal denervation for uncontrolled hypertension in Sweden
Kahan T; Johansen ML; Ryschon AM; Cao KN; Kolovetsios MD; Lindgren P; Pietzsch JB
Article: HEART AND VESSELS. 2025;40(10):895-904
Overnight stiffness index from finger photoplethysmography in relation to markers of cardiovascular risk and vascular ageing
Hellqvist H; Rietz H; Grote L; Hedner J; Sommermeyer D; Kahan T; Spaak J
Article: RESUSCITATION PLUS. 2025;21:100839
Exploring the impact of age on the predictive power of the National Early Warning score (NEWS) 2, and long-term prognosis among patients reviewed by a Rapid Response Team: A prospective, multi-centre study
Thoren A; Franko MA; Joelsson-Alm E; Rawshani A; Kahan T; Engdahl J; Jonsson M; Djarv T; Spangfors M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2025;34(1):e70075
Have People Treated With Antihypertensives Been Diagnosed With Hypertension? A Cross-Sectional Study in Stockholm, Sweden
Treciokiene I; Forslund T; Kahan T; Taxis K; Wettermark B
Article: BLOOD PRESSURE. 2024;33(1):2368800
Management of patients with hypertension and chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. On behalf of the European Society of Hypertension Working Group on Hypertension and the Kidney
Halimi J-M; Sarafidis P; Azizi M; Bilo G; Burkard T; Bursztyn M; Camafort M; Chapman N; Cottone S; de Backer T; Deinum J; Delmotte P; Dorobantu M; Doumas M; Dusing R; Duly-Bouhanick B; Fauvel J-P; Fesler P; Gaciong Z; Gkaliagkousi E; Gordin D; Grassi G; Grassos C; Guerrot D; Huart J; Izzo R; Aguila FJ; Jarai Z; Kahan T; Kantola I; Kocianova E; Limbourg F; Lopez-Sublet M; Mallamaci F; Manolis A; Marketou M; Mayer G; Mazza A; MacIntyre I; Mourad J-J; Muiesan ML; Nasr E; Nilsson P; Oliveras A; Ormezzano O; Paixao-Dias V; Papadakis I; Papadopoulos D; Perl S; Polonia J; Pontremoli R; Pucci G; Robles NR; Rubin S; Ruilope LM; Rump LC; Saeed S; Sanidas E; Sarzani R; Schmieder R; Silhol F; Sokolovic S; Solbu M; Soucek M; Stergiou G; Sudano I; Tabbalat R; Tengiz I; Triantafyllidi H; Tsioufis K; Vaclavik J; van der Giet M; Van der Niepen P; Veglio F; Venzin R; Viigimaa M; Weber T; Widimsky J; Wuerzner G; Zelveian P; Zebekakis P; Lueders S; Persu A; Kreutz R; Vogt L
Article: PLATELETS. 2024;35(1):2437768
Alterations in platelet activity and endothelial glycocalyx biomarkers by treatment with an angiotensin converting enzyme inhibitor or an alpha-1 adrenoceptor antagonist in patients with hypertension: results from the DoRa study
Ekholm M; Jekell A; Lundwall K; Alfredsson J; Lindahl TL; Wallen H; Kahan T
Article: JOURNAL OF HYPERTENSION. 2024;42(12):2065-2074
The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)
Wojciechowska W; Rajzer M; Kreutz R; Weber T; Bursztyn M; Persu A; Stergiou G; Parati G; Bilo G; Pac A; Grassi G; Mancia G; Januszewicz A; Chrostowska M; Narkiewicz K; Dubiela A; Doumas M; Imprialos K; Stavropoulos K; de Freminville J-B; Azizi M; Cunha PG; Lewandowski J; Strzelczyk J; Wuerzner G; Gosk-Przybylek M; Szwench-Pietrasz E; Prejbisz A; Van der Niepen P; Kahan T; Jekell A; Spaak J; Tsioufis K; Ehret G; Doroszko A; Kubalski P; Polonia J; Styczkiewicz K; Styczkiewicz M; Mazur S; Veglio F; Rabbia F; Eula E; Aguila FJ; Sarzani R; Spannella F; Jarai Z; Papadopoulos D; Lopez-Sublet M; Ostrowska A; Grassos C; Kahrimanidis I; Eugenia G; Areti T; Tomasz G; Barbara W; Aleksandra S; Beata M; Angeliki N; Robles NR; Widmiski J; Zbroch E
Article: EUROPEAN HEART JOURNAL: DIGITAL HEALTH. 2024;6(1):104-114
Performance of computerized self-reported medical history taking and HEAR score for safe early rule-out of cardiac events in acute chest pain patients: the CLEOS-CPDS prospective cohort study
Brandberg H; Schierenbeck F; Sundberg CJ; Koch S; Spaak J; Kahan T
Article: CLINICAL KIDNEY JOURNAL. 2024;17(11):sfae331
Integrated, person-centred care for patients with complex cardiovascular disease, diabetes mellitus and chronic kidney disease: a randomized trial
Even G; Stenfors T; Jacobson SH; Jernberg T; Franzen-Dahlin A; Jaghult S; Kahan T; Spaak J
Article: JOURNAL OF HYPERTENSION. 2024;42(9):1544-1554
Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire
Halimi J-M; Sarafidis P; Azizi M; Bilo G; Burkard T; Bursztyn M; Camafort M; Chapman N; Cottone S; de Backer T; Deinum J; Delmotte P; Dorobantu M; Doumas M; Dusing R; Duly-Bouhanick B; Fauvel J-P; Fesler P; Gaciong Z; Gkaliagkousi E; Gordin D; Grassi G; Grassos C; Guerrot D; Huart J; Izzo R; Aguila FJ; Jarai Z; Kahan T; Kantola I; Kocianova E; Limbourg FP; Lopez-Sublet M; Mallamaci F; Manolis A; Marketou M; Mayer G; Mazza A; MacIntyre IM; Mourad J-J; Muiesan ML; Nasr E; Nilsson P; Oliveras A; Ormezzano O; Paixao-Dias V; Papadakis I; Papadopoulos D; Perl S; Polonia J; Pontremoli R; Pucci G; Robles NR; Rubin S; Ruilope LM; Rump LC; Saeed S; Sanidas E; Sarzani R; Schmieder R; Silhol F; Sokolovic S; Solbu M; Soucek M; Stergiou G; Sudano I; Tabbalat R; Tengiz I; Triantafyllidi H; Tsioufis K; Vaclavik J; van der Giet M; Van der Niepen P; Veglio F; Venzin RM; Viigimaa M; Weber T; Widimsky J; Wuerzner G; Zelveian P; Zebekakis P; Lueders S; Persu A; Kreutz R; Vogt L
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2024;11:1449168
Assessment of aortic stiffness during atrial fibrillation: solutions and considerations
Lundwall K; Al Nouh M; Kahan T; Spaak J
Article: PREVENTIVE MEDICINE REPORTS. 2024;44:102806
Predicting new cases of hypertension in Swedish primary care with a machine learning tool
Norrman A; Hasselstrom J; Ljunggren G; Wachtler C; Eriksson J; Kahan T; Wandell P; Gudjonsdottir H; Lindblom S; Ruge T; Rosenblad A; Brynedal B; Carlsson AC
Article: JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION. 2024;31(7):1529-1539
Are medical history data fit for risk stratification of patients with chest pain in emergency care? Comparing data collected from patients using computerized history taking with data documented by physicians in the electronic health record in the CLEOS-CPDS prospective cohort study
Brandberg H; Sundberg CJ; Spaak J; Koch S; Kahan T
Article: TOPICS IN STROKE REHABILITATION. 2024;32(1):1-10
Effects of different exercise protocols on aerobic capacity, blood pressure, biochemical parameters, and body weight in chronic stroke survivors: a randomized controlled trial
Palmcrantz S; Cremoux A; Kahan T; Borg J
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2024;31(7):812-821
Long-term secondary prevention and outcome following acute coronary syndrome: real-world results from the Swedish Primary Care Cardiovascular Database
Bentzel S; Ljungman C; Hjerpe P; Schioler L; Manhem K; Bostrom KB; Kahan T; Mourtzinis G
Article: BMJ OPEN QUALITY. 2024;13(1):e002475
Lack of associations between hospital rating and outcomes in patients with an acute coronary syndrome
Aspberg S; Kahan T; Johansson F
Article: FRONTIERS IN CARDIOVASCULAR MEDICINE. 2024;11:1350726
Estimation of aortic stiffness by finger photoplethysmography using enhanced pulse wave analysis and machine learning
Hellqvist H; Karlsson M; Hoffman J; Kahan T; Spaak J
Article: CLINICAL KIDNEY JOURNAL. 2024;17(3):sfae050
Associations between inflammatory and angiogenic proteomic biomarkers, and cardiovascular events and mortality in relation to kidney function
Salzinger B; Lundwall K; Evans M; Moertberg J; Wallen H; Jernberg T; Kahan T; Lundman P; Tornvall P; Erlinge D; Lindahl B; Baron T; Rezeli M; Spaak J; Jacobson SH
Article: AMERICAN HEART JOURNAL. 2024;269:118-130
Intensity of and adherence to lipid-lowering therapy as predictors of goal attainment and major adverse cardiovascular events in primary prevention
Mazhar F; Hjemdahl P; Sjolander A; Kahan T; Jernberg T; Carrero JJ
Article: HYPERTENSION RESEARCH. 2024;47(2):435-444
Blood pressure in atrial fibrillation and in sinus rhythm during ambulatory blood pressure monitoring: data from the TEMPLAR project
Lundwall K; Kahan T; Omboni S
Article: PATIENT PREFERENCE AND ADHERENCE. 2023;17:3331-3339
A Qualitative Study on Patients' Views on Hypertension and Antihypertensive Medications
Malkon S; Wettermark B; Kahan T; Bastholm-Rahmner P; Hasselstrom J; Qvarnstrom M
Article: RESUSCITATION. 2023;193:109978
Rapid response team activation prior to in-hospital cardiac arrest: Areas for improvements based on a national cohort study
Thoren A; Jonsson M; Spangfors M; Joelsson-Alm E; Jakobsson J; Rawshani A; Kahan T; Engdahl J; Jadenius A; von Platen EB; Herlitz J; Djarv T
Article: EUROPEAN HEART JOURNAL. 2023;44(15):1313-1330
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E; Azizi M; Schmieder RE; Lauder L; Boehm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Luscher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
Article: JOURNAL OF HYPERTENSION. 2023;41(4):527-544
Blood pressure variability: methodological aspects, clinical relevance and practical indications for management-a European Society of Hypertension position paper*
Parati G; Bilo G; Kollias A; Pengo M; Ochoa JE; Castiglioni P; Stergiou GS; Mancia G; Asayama K; Asmar R; Avolio A; Caiani EG; De La Sierra A; Dolan E; Grillo A; Guzik P; Hoshide S; Head GA; Imai Y; Juhanoja E; Kahan T; Kario K; Kotsis V; Kreutz R; Kyriakoulis KG; Li Y; Manios E; Mihailidou AS; Modesti PA; Omboni S; Palatini P; Persu A; Protogerou AD; Saladini F; Salvi P; Sarafidis P; Torlasco C; Veglio F; Vlachopoulos C; Zhang Y
Article: EUROINTERVENTION. 2023;18(15):1227-1243
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E; Azizi M; Schmieder RE; Lauder L; Boehm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Luescher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2023;373:64-71
Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function
Mortberg J; Salzinger B; Lundwall K; Edfors R; Jacobson SH; Wallen HN; Jernberg T; Baron T; Erlinge D; Andell P; James S; Eggers KM; Hjort M; Kahan T; Lundman P; Tornvall P; Rezeli M; Marko-Varga G; Lindahl B; Spaak J
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2023;30(1):48-60
New perspectives for hypertension management: progress in methodological and technological developments
Parati G; Goncalves A; Soergel D; Bruno RM; Caiani EG; Gerdts E; Mahfoud F; Mantovani L; McManus RJ; Santalucia P; Kahan T
Article: BLOOD PRESSURE. 2022;31(1):91-99
Aortic stiffness and aortic-brachial stiffness mismatch as markers of renal dysfunction in hypertension
Lundwall K; Jekell A; Desta L; Jacobson SH; Kahan T; Spaak J
Article: BLOOD PRESSURE. 2022;31(1):71-79
Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension
Weber T; Amar J; de Backer T; Burkard T; van der Giet M; Gosse P; Januszewicz A; Kahan T; Mancia G; Mayer CC; Muiesan ML; Stergiou GS; Tsioufis K; Vaisse B; Kreutz R
Article: EUROPEAN HEART JOURNAL. 2022;43(46):4777-4788
Sex differences in arterial hypertension A scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association of Cardiovascular Nursing and Allied Professions, the ESC Council for Cardiology Practice, and the ESC Working Group on Cardiovascular Pharmacotherapy
Gerdts E; Sudano I; Brouwers S; Borghi C; Bruno RM; Ceconi C; Cornelissen V; Dievart F; Ferrini M; Kahan T; Lochen ML; Maas AHEM; Mahfoud F; Mihailidou AS; Moholdt T; Parati G; de Simone G
Article: NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES. 2022;32(12):2803-2810
Prediabetes and incident heart failure in hypertensive patients: Results from the Swedish Primary Care Cardiovascular Database
Johansson JSM; Hjerpe P; Mourtzinis G; Kahan T; Ljungman C
Article: HEALTH EXPECTATIONS. 2022;25(6):3053-3061
User experience of self-reported computerized medical history taking for acute chest pain: The Clinical Expert Operating System Chest Pain Danderyd Study
Sundberg K; Adeli A; Brandberg H; Spaak J; Koch S; Sundberg CJ; Zakim D; Kahan T; Fritzell K
Article: HYPERTENSION RESEARCH. 2022;45(9):1486-1495
24-hour ambulatory blood pressure telemonitoring in patients at risk of atrial fibrillation: results from the TEMPLAR project
Omboni S; Ballatore T; Rizzi F; Tomassini F; Campolo L; Panzeri E; Lundwall K; Kahan T
Article: RESUSCITATION PLUS. 2022;9:100191
The predictive power of the National Early Warning Score (NEWS) 2, as compared to NEWS, among patients assessed by a Rapid response team: A prospective multi-centre trial
Thoren A; Joelsson-Alm E; Spangfors M; Rawshani A; Kahan T; Engdahl J; Jonsson M; Djarv T
Article: MICROCIRCULATION. 2022;29(2):e12747
Skin microvascular reactivity and subendocardial viability ratio in relation to dyslipidemia and signs of insulin resistance in non-diabetic hypertensive patients
Jekell A; Kalani M; Kahan T
Article: ATHEROSCLEROSIS. 2021;338:55-63
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement
Belch JJF; Brodmann M; Baumgartner I; Binder CJ; Casula M; Heiss C; Kahan T; Parini P; Poredos P; Catapano AL; Tokgozoglu L
Article: HYPERTENSION. 2021;78(5):1241-1247
Heart Failure Events in a Clinical Trial on Arterial Hypertension: New Insights Into the SPRINT Trial
Sobieraj P; Nilsson PM; Kahan T
Article: SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE. 2021;39(4):519-526
Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database
Mourtzinis G; Manhem K; Kahan T; Schioler L; Isufi J; Ljungman C; Andersson T; Hjerpe P
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2021;78(4):551-559
Altered Vascular Reactivity to Circulating Angiotensin II in Familial Hypercholesterolemia
Ekholm M; Wallen HN; Brinck J; Jorneskog G; Kahan T
Article: EUROPEAN HEART JOURNAL OPEN. 2021;1(1):oeab021
Open Up your Science in EHJ Open
Back M; Banach M; Braunschweig F; De Rosa S; Gimelli A; Kahan T; Ketelhuth DFJ; Lancellotti P; Larsson SC; Mellbin L; Nagy E; Savarese G; Szummer K; Wahl D
Article: JOURNAL OF HYPERTENSION. 2021;39(8):1522-1545
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension
Kasiakogias A; Rosei EA; Camafort M; Ehret G; Faconti L; Ferreira JP; Brguljan J; Januszewicz A; Kahan T; Manolis A; Tsioufis K; Weber T; von Lueder TG; Smiseth OA; Wachtell K; Kjeldsen SE; Zannad F; Mancia G; Kreutz R
Article: JOURNAL OF HYPERTENSION. 2021;39(8):1670-1677
Blood pressure levels and risk of haemorrhagic stroke in patients with atrial fibrillation and oral anticoagulants: results from The Swedish Primary Care Cardiovascular Database of Skaraborg
Bager J-E; Hjerpe P; Schioler L; Bengtsson Bostrom K; Kahan T; Odesjo H; Jood K; Hasselstrom J; Ljungman C; Manhem K; Mourtzinis G
Article: JOURNAL OF HYPERTENSION. 2021;39(6):1155-1162
Country of birth and mortality risk in hypertension with and without diabetes: the Swedish primary care cardiovascular database
Andersson T; Pikkemaat M; Schioeler L; Hjerpe P; Carlsson AC; Wandell P; Manhem K; Kahan T; Bostroem KB
Article: JOURNAL OF MEDICAL INTERNET RESEARCH. 2021;23(4):e25493
Use of Self-Reported Computerized Medical History Taking for Acute Chest Pain in the Emergency Department - the Clinical Expert Operating System Chest Pain Danderyd Study (CLEOS-CPDS): Prospective Cohort Study
Brandberg H; Sundberg CJ; Spaak J; Koch S; Zakim D; Kahan T
Article: MICROCIRCULATION. 2021;28(2):e12670
Effects of exenatide on microvascular reactivity in patients with type 2 diabetes and coronary artery disease: A randomized controlled study
Papadogeorgos NO; Kuhl J; Shore A; Kahan T; Jorneskog G; Kalani M
Article: JOURNAL OF HYPERTENSION. 2021;39(1):190-195
The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension
Weber T; Januszewicz A; Rosei EA; Tsioufis K; Okorie M; Stergiou GS; Volpe M; Kreutz R; Abraham G; Azizi M; Barna I; Barroso WKS; Brguljan J; Chapman N; De Backer T; Dorobantu M; Eckert S; Gaciong Z; Giannattasio C; Glover M; Gottsaeter A; Grassos C; Jarai Z; Aguila FJ; Kahan T; Lopez-Sublet M; Lovic D; Lurbe E; Makris TK; Mallamaci F; Manolis AJ; Marketou M; Mazza A; Mediavilla JD; Muiesan ML; Muxfeldt ES; Nasr E; Papadakis I; Parounak Z; Obregon S; Okorie M; Oliveras A; Pontremoli R; Raev D; Rajkumar C; Redon J; Robles NR; Rump LC; Sarzani R; Sierra C; Sirenko Y; Stojanov V; Tikkanen I; Vaclavik J; Veglio F; Viigimaa M; Webb D; Zebekakis P; Zweiker R
Article: PLOS ONE. 2021;16(9):e0257677
Computerized history-taking improves data quality for clinical decision-making-Comparison of EHR and computer-acquired history data in patients with chest pain
Zakim D; Brandberg H; El Amrani S; Hultgren A; Stathakarou N; Nifakos S; Kahan T; Spaak J; Koch S; Sundberg CJ; Bahl A; Bahl A; Bahl A; Bahl A
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2020;6(6):384-393
Peripartum management of hypertension: a position paper of the ESC Council on Hypertension and the European Society of Hypertension
Cifkova R; Johnson MR; Kahan T; Brguljan J; Williams B; Coca A; Manolis A; Thomopoulos C; Borghi C; Tsioufis C; Parati G; Sudano I; McManus RJ; van den Born B-JH; Regitz-Zagrosek V; de Simone G
Article: JOURNAL OF INTERNAL MEDICINE. 2020;288(5):581-592
Use of proteomics to identify biomarkers associated with chronic kidney disease and long-term outcomes in patients with myocardial infarction
Edfors R; Lindhagen L; Spaak J; Evans M; Andell P; Baron T; Mortberg J; Rezeli M; Salzinger B; Lundman P; Szummer K; Tornvall P; Wallen HN; Jacobson SH; Kahan T; Marko-Varga G; Erlinge D; James S; Lindahl B; Jernberg T
Article: PLOS ONE. 2020;15(8):e0237107
The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: A cohort study from the Swedish Primary Care Cardiovascular Database (SPCCD)
Andersson T; Pikkemaat M; Schioler L; Hjerpe P; Carlsson AC; Wandell P; Manhem K; Kahan T; Hasselstrom J; Bengtsson Bostrom K
Article: BLOOD PRESSURE. 2020;29(3):168-174
Current antihypertensive drug therapy in 12,436 Swedish patients, 90 years and above, in relation to sex and comorbidity
Wallentin F; Wettermark B; Kahan T
Article: JOURNAL OF HYPERTENSION. 2020;38(5):799-812
Nutraceuticals and blood pressure control: a European Society of Hypertension position document
Borghi C; Tsioufis K; Agabiti-Rosei E; Burnier M; Cicero AFG; Clement D; Coca A; Desideri G; Grassi G; Lovic D; Lurbe E; Kahan T; Kreutz R; Jelakovic B; Polonia J; Redon J; Van de Borne P; Mancia G
Article: RESUSCITATION. 2020;150:130-138
ECG -monitoring of in -hospital cardiac arrest and factors associated with survival
Thoren A; Rawshani A; Herlitz J; Engdahl J; Kahan T; Gustafsson L; Djarv T
Article: ESC HEART FAILURE. 2020;7(2):737-746
The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study
Ekstrom M; Hellman A; Hasselstrom J; Hage C; Kahan T; Ugander M; Wallen H; Persson H; Linde C
Article: BMJ OPEN. 2020;10(1):e031871
A prospective cohort study of self-reported computerised medical history taking for acute chest pain: protocol of the CLEOS-Chest Pain Danderyd Study (CLEOS-CPDS)
Brandberg H; Kahan T; Spaak J; Sundberg K; Koch S; Adeli A; Sundberg CJ; Zakim D
Article: BIOMED RESEARCH INTERNATIONAL. 2020;2020:8571062
Oscillometrically Measured Aortic Pulse Wave Velocity Reveals Asymptomatic Carotid Atherosclerosis in a Middle-Aged, Apparently Healthy Population
Bocskei RM; Benczur B; Muller V; Bikov A; Szekely A; Kahan T; Lenkey Z; Husznai R; Cziraki A; Illyes M
Article: JOURNAL OF HYPERTENSION. 2020;38(1):167-175
Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database
Bokrantz T; Schioler L; Bostrom KB; Kahan T; Mellstrom D; Ljungman C; Hjerpe P; Hasselstrom J; Manhem K
Article: BLOOD PRESSURE. 2019;28(5):309-316
Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients
Qvarnstrom M; Kahan T; Kieler H; Brandt L; Hasselstrom J; Wettermar B
Article: VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 2019;48(Suppl 102):1-79
ESVM Guideline on peripheral arterial disease
Frank U; Nikol S; Belch J; Boc V; Brodmann M; Carpentier PH; Chraim A; Canning C; Dimakakos E; Gottsater A; Heiss C; Mazzolai L; Madaric J; Olinic DM; Pecsvarady Z; Poredos P; Quere I; Roztocil K; Stanek A; Vasic D; Visona A; Wautrecht J-C; Bulvas M; Colgan M-P; Dorigo W; Houston G; Kahan T; Lawall H; Lindstedt I; Mahe G; Martini R; Pernod G; Przywara S; Righini M; Schlager O; Terlecki P
Article: HEART AND VESSELS. 2019;34(3):484-495
The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril study
Jekell A; Kalani M; Kahan T
Article: DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION. 2019;2019:baz085
Large expert-curated database for benchmarking document similarity detection in biomedical literature search
Brown P; Tan A-C; El-Esawi MA; Liehr T; Blanck O; Gladue DP; Almeida GMF; Cernava T; Sorzano CO; Yeung AWK; Engel MS; Chandrasekaran AR; Muth T; Staege MS; Daulatabad SV; Widera D; Zhang J; Meule A; Honjo K; Pourret O; Yin C-C; Zhang Z; Cascella M; Flegel WA; Goodyear CS; van Raaij MJ; Bukowy-Bieryllo Z; Campana LG; Kurniawan NA; Lalaouna D; Huttner FJ; Ammerman BA; Ehret F; Cobine PA; Tan E-C; Han H; Xia W; McCrum C; Dings RPM; Marinello F; Nilsson H; Nixon B; Voskarides K; Yang L; Costa VD; Bengtsson-Palme J; Bradshaw W; Grimm DG; Kumar N; Martis E; Prieto D; Sabnis SC; Amer SEDR; Liew AWC; Perco P; Rahimi F; Riva G; Zhang C; Devkota HP; Ogami K; Basharat Z; Fierz W; Siebers R; Tan K-H; Boehme KA; Brenneisen P; Brown JAL; Dalrymple BP; Harvey DJ; Ng G; Werten S; Bleackley M; Dai Z; Dhariwal R; Gelfer Y; Hartmann MD; Miotla P; Tamaian R; Govender P; Gurney-Champion OJ; Kauppila JH; Zhang X; Echeverria N; Subhash S; Sallmon H; Tofani M; Bae T; Bosch O; Cuiv PO; Danchin A; Diouf B; Eerola T; Evangelou E; Filipp FV; Klump H; Kurgan L; Smith SS; Terrier O; Tuttle N; Ascher DB; Janga SC; Schulte LN; Becker D; Browngardt C; Bush SJ; Gaullier G; Ide K; Meseko C; Werner GDA; Zaucha J; Al-Farha AA; Greenwald NF; Popoola SI; Rahman MS; Xu J; Yang SY; Hiroi N; Alper OM; Baker CI; Bitzer M; Chacko G; Debrabant B; Dixon R; Forano E; Gilliham M; Kelly S; Klempnauer K-H; Lidbury BA; Lin MZ; Lynch I; Ma W; Maibach EW; Mather DE; Nandakumar KS; Ohgami RS; Parchi P; Tressoldi P; Xue Y; Armitage C; Barraud P; Chatzitheochari S; Coelho LP; Diao J; Doxey AC; Gobet A; Hu P; Kaiser S; Mitchell KM; Salama MF; Shabalin IG; Song H; Stevanovic D; Yadollahpour A; Zeng E; Zinke K; Alimba CG; Beyene TJ; Cao Z; Chan SS; Gatchell M; Kleppe A; Piotrowski M; Torga G; Woldesemayat AA; Cosacak MI; Haston S; Ross SA; Williams R; Wong A; Abramowitz MK; Effiong A; Lee S; Abid MB; Agarabi C; Alaux C; Albrecht DR; Atkins GJ; Beck CR; Bonvin AMJJ; Bourke E; Brand T; Braun RJ; Bull JA; Cardoso P; Carter D; Delahay RM; Ducommun B; Duijf PHG; Epp T; Eskelinen E-L; Fallah M; Farber DB; Fernandez-Triana J; Feyerabend F; Florio T; Friebe M; Furuta S; Gabrielsen M; Gruber J; Grybos M; Han Q; Heinrich M; Helantera H; Huber M; Jeltsch A; Jiang F; Josse C; Jurman G; Kamiya H; de Keersmaecker K; Kristiansson E; de Leeuw F-E; Li J; Liang S; Lopez-Escamez JA; Lopez-Ruiz FJ; Marchbank KJ; Marschalek R; Martin CS; Miele AE; Montagutelli X; Morcillo E; Nicoletti R; Niehof M; O'Toole R; Ohtomo T; Oster H; Palma J-A; Paterson R; Peifer M; Portilla M; Portillo MC; Pritchard AL; Pusch S; Raghava GPS; Roberts NJ; Ross K; Schuele B; Sergeant K; Shen J; Stella A; Sukocheva O; Uversky VN; Vanneste S; Villet MH; Viveiros M; Vorholt JA; Weinstock C; Yamato M; Zabetakis I; Zhao X; Ziegler A; Aizat WM; Atlas L; Bridges KM; Chakraborty S; Deschodt M; Domingues HS; Esfahlani SS; Falk S; Guisado JL; Kane NC; Kueberuwa G; Lau CL; Liang D; Liu E; Luu AM; Ma C; Ma L; Moyer R; Norris AD; Panthee S; Parsons JR; Peng Y; Pinto IM; Reschke CR; Sillanpaa E; Stewart CJ; Uhle F; Yang H; Zhou K; Zhu S; Ashry M; Bergsland N; Berthold M; Chen C-E; Colella V; Cuypers M; Eskew EA; Fan X; Gajda M; Gonzalezlez-Prendes R; Goodin A; Graham EB; Groen EJN; Gutierrez-Sacristan A; Habes M; Heffler E; Higginbottom DB; Janzen T; Jayaraman J; Jibb LA; Jongen S; Kinyanjui T; Koleva-Kolarova RG; Li Z; Liu Y-P; Lund BA; Lussier AA; Ma L; Mier P; Moore MD; Nagler K; Orme MW; Pearson JA; Prajapati AS; Saito Y; Troder SE; Uchendu F; Verloh N; Voutchkova DD; Abu-Zaid A; Bakkach J; Baumert P; Dono M; Hanson J; Herbelet S; Hobbs E; Kulkarni A; Kumar N; Liu S; Loft ND; Reddan T; Senghore T; Vindin H; Xu H; Bannon R; Chen B; Cheung JTK; Cooper J; Esnakul AK; Feghali KA; Ghelardi E; Gnasso A; Horbar J; Lai HM; Li J; Ma L; Ma R; Pan Z; Peres MA; Pranata R; Seow E; Sydes M; Testoni I; Westermair AL; Yang Y; Afnan M; Albiol J; Albuquerque LG; Amiya E; Amorim RM; An Q; Andersen SU; Aplin JD; Argyropoulos C; Asmann YW; Assaeed AM; Atanasov AG; Atchison DA; Avery SV; Avillach P; Baade PD; Backman L; Badie C; Baldi A; Ball E; Bardot O; Barnett AG; Basner M; Batra J; Bazanova OM; Beale A; Beddoe T; Bell ML; Berezikov E; Berners-Price S; Bernhardt P; Berry E; Bessa TB; Billington C; Birch J; Blakely RD; Blaskovich MAT; Blum R; Boelaert M; Bogdanos D; Bosch C; Bourgoin T; Bouvard D; Boykin LM; Bradley G; Braun D; Brownlie J; Bruhl A; Burt A; Butler LM; Byrareddy SN; Byrne HJ; Cabantous S; Calatayud S; Candal E; Carlson K; Casillas S; Castelvetro V; Caswell PT; Cavalli G; Cerovsky V; Chagoyen M; Chen C-S; Chen DF; Chen H; Chen H; Chen J-T; Chen Y; Cheng C; Cheng J; Chinapaw M; Chinopoulos C; Cho WCS; Chong L; Chowdhury D; Chwalibog A; Ciresi A; Cockcroft S; Conesa A; Cook PA; Cooper DN; Coqueret O; Corea EM; Costa E; Coupland C; Crawford SY; Cruz AD; Cui H; Cui Q; Culver DC; D'Angiulli A; Dahms TES; Daigle F; Dalgleish R; Danielsen HE; Darras S; Davidson SM; Day DA; Degirmenci V; Demaison L; Devriendt K; Ding J; Dogan Y; Dong XC; Donner CF; Dressick W; Drevon CA; Duan H; Ducho C; Dumaz N; Dwarakanath BS; Ebell MH; Eisenhardt S; Elkum N; Engel N; Erickson TB; Fairhead M; Faville MJ; Fejzo MS; Festa F; Feteira A; Flood-Page P; Forsayeth J; Fox SA; Franks SJ; Frentiu FD; Frilander MJ; Fu X; Fujita S; Galea I; Galluzzi L; Gani F; Ganpule AP; Garcia-Alix A; Gedye K; Giordano M; Giunta C; Gleeson PA; Goarant C; Gong H; Gora D; Gough MJ; Goyal R; Graham KE; Grande-Perez A; Graves PM; Greidanus H; Grice D; Grunau C; Gumulya Y; Guo Y; Gurevich VV; Gusev O; Hacker E; Hage SR; Hagen G; Hahn S; Haller DM; Hammerschmidt S; Han J; Han R; Handfield M; Hapuarachchi HC; Harder T; Hardingham JE; Heck M; Heers M; Hew KF; Higuchi Y; St Hilaire C; Hilton R; Hodzic E; Hone A; Hongoh Y; Hu G; Huber HP; Hueso LE; Huirne J; Hurt L; Idborg H; Ikeo K; Ingley E; Jakeman PM; Jensen A; Jia H; Jia H; Jia S; Jiang J; Jiang X; Jin Y; Jo D; Johnson AM; Johnston M; Jonscher KR; Jorens PG; Jorgensen JOL; Joubert JW; Jung S-H; Junior AM; Kahan T; Kamboj SK; Kang Y-K; Karamanos Y; Karp NA; Kelly R; Kenna R; Kennedy J; Kersten B; Khalaf RA; Khalid JM; Khatlani T; Khider T; Kijanka GS; King SRB; Kluz T; Knox P; Kobayashi T; Koch K-W; Kohonen-Corish MRJ; Kong X; Konkle-Parker D; Korpela KM; Kostrikis LG; Kraiczy P; Kratz H; Krause G; Krebsbach PH; Kristensen SR; Kumari P; Kunimatsu A; Kurdak H; Kwon YD; Lachat C; Lagisz M; Laky B; Lammerding J; Lange M; Larrosa M; Laslett AL; LeClair EE; Lee K-W; Lee M-Y; Lee M-S; Li G; Li J; Lieb K; Lim YY; Lindsey ML; Line P-D; Liu D; Liu F; Liu H; Liu H; Lloyd VK; Lo T-W; Locci E; Loidl J; Lorenzen J; Lorkowski S; Lovell NH; Lu H; Lu W; Lu Z; Luengo GS; Lundh L-G; Lysy PA; Mabb A; Mack HG; Mackey DA; Mahdavi SR; Maher P; Maher T; Maity SN; Malgrange B; Mamoulakis C; Mangoni AA; Manke T; Manstead ASR; Mantalaris A; Marsal J; Marschall H-U; Martin FL; Martinez-Raga J; Martinez-Salas E; Mathieu D; Matsui Y; Maza E; McCutcheon JE; Mckay GJ; McMillan B; McMillan N; Meads C; Medina L; Merrick BA; Metzger DW; Meunier FA; Michaelis M; Micheau O; Mihara H; Mintz EM; Mizukami T; Moalic Y; Mohapatra DP; Monteiro A; Montes M; Moran JV; Morozov SY; Mort M; Murai N; Murphy DJ; Murphy SK; Murray SA; Naganawa S; Nammi S; Nasios G; Natoli RM; Nguyen F; Nicol C; van Nieuwerburgh F; Nilsen EB; Nobile CJ; O'Mahony M; Ohlsson S; Olatunbosun O; Olofsson P; Ortiz A; Ostrikov K; Otto S; Outeiro TF; Ouyang S; Paganoni S; Page A; Palm C; Paradies Y; Parsons MH; Parsons N; Pascal P; Paul E; Peckham M; Pedemonte N; Pellizzon MA; Petrelli M; Pichugin A; Pinto CJC; Plevris JN; Pollesello P; Polz M; Ponti G; Porcelli P; Prince M; Quinn GP; Quinn TJ; Ramula S; Rappsilber J; Rehfeldt F; Reiling JH; Remacle C; Rezaei M; Riddick EW; Ritter U; Roach NW; Roberts DD; Robles G; Rodrigues T; Rodriguez C; Roislien J; Roobol MJ; Rowe JA; Ruepp A; van Ruitenbeek J; Rust P; Saad S; Sack GH; Santos M; Saudemont A; Sava G; Schrading S; Schramm A; Schreiber M; Schuler S; Schymkowitz J; Sczyrba A; Seib KL; Shi H-P; Shimada T; Shin J-S; Shortt C; Silveyra P; Skinner D; Small I; Smeets PAM; So P-W; Solano F; Sonenshine DE; Song J; Southall T; Speakman JR; Srinivasan MV; Stabile LP; Stasiak A; Steadman KJ; Stein N; Stephens AW; Stewart DI; Stine K; Storlazzi C; Stoynova NV; Strzalka W; Suarez OM; Sultana T; Sumant AV; Summers MJ; Sun G; Tacon P; Tanaka K; Tang H; Tanino Y; Targett-Adams P; Tayebi M; Tayyem R; Tebbe CC; Telfer EE; Tempel W; Teodorczyk-Injeyan JA; Thijs G; Thorne S; Thrift AG; Tiffon C; Tinnefeld P; Tjahjono DH; Tolle F; Toth E; del Tredici AL; Tsapas A; Tsirigotis K; Turak A; Tzotzos G; Udo EE; Utsumi T; Vaidyanathan S; Vaillant M; Valsesia A; Vandenbroucke RE; Veiga FH; Vendrell M; Vesk PA; Vickers P; Victor VM; Villemur R; Vohl M-C; Voolstra CR; Vuillemin A; Wakelin S; Waldron L; Walsh LJ; Wang AY; Wang F; Wang Y; Watanabe Y; Weigert A; Wen J-C; Wham C; White EP; Wiener J; Wilharm G; Wilkinson S; Willmann R; Wilson C; Wirth B; Wojan TR; Wolff M; Wong BM; Wu T-W; Wuerbel H; Xiao X; Xu D; Xu JW; Xu J; Xue B; Yalcin S; Yan H; Yang E-C; Yang S; Yang W; Ye Y; Ye Z-Q; Yli-Kauhaluoma J; Yoneyama H; Yu Y; Yuan G-C; Yuh C-H; Zaccolo M; Zeng C; Zevnik B; Zhang C; Zhang L; Zhang L; Zhang Y; Zhang Y; Zhang Z; Zhang Z-Y; Zhao Y; Zhou M; Zuberbier T; Aanei CM; Ahmad R; Al-Lawama M; Alanio A; Allardyce J; Alonso-Caneiro D; Atack JM; Baier D; Bansal A; Benezeth Y; Berbesque C; Berrevoet F; Biedermann PHW; Bijleveld E; Bittner F; Blombach F; Van den Bos W; Boudreau SA; Bramoweth AD; Braubach O; Cai Y; Campbell M; Cao Z; Catry T; Chen X; Cheng S; Chung H-J; Chavez-Fumagalli MA; Conway A; Costa BM; Cyr N; Dean LT; Denzel MS; Dlamini SV; Dudley KJ; Dufies M; Ecke T; Eckweiler D; Eixarch E; El-Adawy H; Emmrich JV; Eustace AJ; Falter-Wagner CM; Fuss J; Gao J; Gill MR; Gloyn L; Goggs R; Govinden U; Greene G; Greiff V; Grundle DS; Gruneberg P; Gumede N; Haore G; Harrison P; Hoenner X; Hojsgaard D; Hori H; Ikonomopoulou MP; Jeurissen P; Johnson DM; Kabra D; Kamagata K; Karmakar C; Kasian O; Kaye LK; Khan MM; Kim Y-M; Kish JK; Kobold S; Kohanbash G; Kohls G; Kugler J-M; Kumar G; Lacy-Colson J; Latif A; Lauschke VM; Li B; Lim CJ; Liu F; Liu X; Lu J-J; Lu Q; Mahavadi P; Marzocchi U; McGarrigle CA; van Meerten T; Min R; Moal I; Molari M; Molleman L; Mondal SR; Van de Mortel T; Moss WN; Moultos OA; Mukherjee M; Nakayama K; Narayan E; Navaratnarajah; Neumann P-A; Nie J; Nie Y; Niemeyer F; Nolan F; Nwaiwu O; Oldenmenger WH; Olumayede E; Ou J; Pallebage-Gamarallage M; Pearce SP; Pelkonen T; Pelleri MC; Pereira JL; Pheko M; Pinto KA; Piovesan A; Pluess M; Podolsky IM; Prescott J; Qi D; Qi X; Raikou VD; Ranft A; Rhodes J; Rotge J-Y; Rowe AD; Saggar M; Schuon RA; Shahid S; Shalchyan V; Shirvalkar P; Shiryayev O; Singh J; Smout MJ; Soares A; Song C; Srivastava K; Srivastava RK; Sun J; Szabo A; Szymanski W; Tai CNP; Takeuchi H; Tanadini-Lang S; Tang F; Tao W; Theron G; Tian CF; Tian Y-S; Tuttle LM; Valenti A; Verlot P; Walker M; Wang J; Welter D; Winslade M; Wu D; Wu Y-R; Xiao H; Xu B; Xu J; Xu Z; Yang D; Yang M; Yankilevich P; You Y; Yu C; Zhan J; Zhang G; Zhang K; Zhang T; Zhang Y; Zhao G; Zhao J; Zhou X; Zhu Z; Ajani PA; Anazodo UC; Bagloee SA; Bail K; Bar I; Bathelt J; Benkeser D; Bernier ML; Blanchard AM; Boakye DW; Bonatsos V; Boon MH; Bouboulis G; Bromfield E; Brown J; Bul KCM; Burton KJ; Butkowski EG; Carroll G; Chao F; Charrier EE; Chen X; Chen Y-C; Chenguang; Choi JR; Christoffersen T; Comel JC; Cosse C; Cui Y; van Dessel P; Dhaval; Diodato D; Duffey M; Dutt A; Egea LG; El-Said M; Faye M; Fernandez-Fernandez B; Foley KG; Founou LL; Fu F; Gadelkareem RA; Galimov E; Garip G; Gemmill A; Gouil Q; Grey J; Gridneva Z; Grothe MJ; Grebert T; Guerrero F; Guignard L; Haenssgen MJ; Hasler D; Holgate JY; Huang A; Hulse-Kemp AM; Jean-Quartier C; Jeon S-M; Jia Y; Jutzeler C; Kalatzis P; Karim M; Karsay K; Keitel A; Kempe A; Keown JR; Khoo CM; Khwaja N; Kievit RA; Kosanic A; Koutoukidis DA; Kramer P; Kumar D; Kirag N; Lanza G; Le TD; Leem JW; Leightley D; Leite A; Lercher L; Li Y; Lim R; Lima LRA; Lin L; Ling T; Liu Y; Liu Z; Lu Y; Lum FM; Luo H; Machhi J; Macleod A; Macwan I; Madala HR; Madani N; de Maio N; Makowiecki K; Mallinson DJ; Margelyte R; Maria C; Markonis Y; Marsili L; Mavoa S; McWilliams L; Megersa M; Mendes CSM; Menichetti J; Mercieca-Bebber R; Miller JJ; Minde D-PM; Minges A; Mishra E; Mishra VR; Moores C; Morrice N; Moskalensky AE; Navarin N; Negera E; Nolet P; Nordberg A; Norden R; Nowicki JP; Olova N; Olszewski P; Onzima R; Pan C-L; Park C; Park DI; Park S; Patil CD; Pedro SA; Perry SR; Peter J; Peterson BM; Pezzuolo A; Pozdnyakov I; Qian S; Qin L; Rafe A; Raote I; Raza A; Rebl H; Refai O; Regan T; Richa T; Richardson MF; Robinson KR; Rossoni L; Rouet R; Safaei S; Schneeberger PHH; Schwotzer D; Sebastian A; Selinski J; Seltmann S; Sha F; Shalev N; Shang J-L; Singer J; Singh M; Smith T; Solomon-Moore E; Song L; Soraggi S; Stanley R; Steckhan N; Strobl F; Subissi L; Supriyanto I; Surve CR; Suzuki T; Syme C; Sorelius K; Tang Y; Tantawy M; Tennakoon S; Teseo S; Toelzer C; Tomov N; Tovar M; Tran L; Tripathi S; Tuladhar AM; Ukubuiwe AC; Ung COL; Valgepea K; Vatanparast H; Vidal A; Wang F; Wang Q; Watari R; Webster R; Webster R; Wei J; Wibowo D; Wingenbach TSH; Xavier RM; Xiao S; Xiong P; Xu S; Xu S; Yao R; Yao W; Yin Q; Yu Y; Zaitsu M; Zeineb Z; Zhan X-Y; Zhang J; Zhang R; Zhang W; Zhang X; Zheng S; Zhou B; Zhou X; Ahmad H; Akinwumi SA; Albery GF; Alhowimel A; Ali J; Alshehri M; Alsuhaibani M; Anikin A; Azubuike SO; Bach-Mortensen A; Baltiansky L; Bartas M; Belachew KY; Bhardwaj V; Binder K; Bland NS; Boah M; Bullen B; Calabro GE; Callahan TJ; Cao B; Chalmers K; Chang W; Che Z; Chen ATY; Chen H; Chen H; Chen Y; Chen Z; Choi Y; Chowdhury MAK; Christensen MR; Cooke RSC; Cottini M; Covington NV; Cunningham C; Delarocque J; Devos L; Dhar AR; Ding K-F; Dong K; Dong Z; Dreyer N; Ekstrand C; Fardet T; Feleke BE; Feurer T; Freitas A; Gao T; Asefa NG; Giganti F; Grabowski P; Guerra-Mora JR; Guo C; Guo X; Gupta H; He S; Heijne M; Heinemann S; Hogrebe A; Huang Z; Iskander-Rizk S; Iyer LM; Jahan Y; James AS; Joel E; Joffroy B; Jegousse C; Kambondo G; Karnati P; Kaya C; Ke A; Kelly D; Kickert R; Kidibule PE; Kieselmann JP; Kim HJ; Kitazawa T; Lamberts A; Li Y; Liang H; Linn SN; Litfin T; Liusuo W; Lygirou V; Mahato AK; Mai Z-M; Major RW; Mali S; Mallis P; Mao W; Mao W; Marvin-Dowle K; Marvin-Dowle K; Mason LD; Merideth B; Merino-Plaza MJ; Merlaen B; Messina R; Mishra AK; Muhammad J; Musinguzi C; Nanou A; Naqash A; Nguyen JT; Nguyen TTH; Ni D; Nida; Notcovich S; Ohst B; Ollivier QR; Osses DF; Peng X; Plantinga A; Pulia M; Rafiq M; Raman A; Raucher-Chene D; Rawski R; Ray A; Razak LA; Rudolf K; Rusch P; Sadoine ML; Schmidt A; Schurr R; Searles S; Sharma S; Sheehan B; Shi C; Shohayeb B; Sommerlad A; Strehlow J; Sun X; Sundar R; Taherzadeh G; Tahir NDM; Tang J; Testa J; Tian Z; Tingting Q; Verheijen GP; Vickstrom C; Wang T; Wang X; Wang Z; Wei P; Wilson A; Wyart; Yassine A-A; Yousefzadeh A; Zare A; Zeng Z; Zhang C; Zhang H; Zhang L; Zhang T; Zhang W; Zhang Z; Zhou J; Zhu D; Adamo V; Adeyemo AA; Aggelidou M; Al-Owaifeer AM; Al-Riyami AZ; Alzghari SK; Andersen V; Angus K; Asaduzzaman M; Asady H; Ato D; Bai X; Baines RL; Ballantyne M; Ban B; Beck J; Ben-Nafa W; Black E; Blancher A; Blankstein R; Bodagh N; Borges PAV; Brooks A; Brox-Ponce J; Brunetti A; Canham CD; Carninci P; Carvajal R; Chang SC; Chao J; Chatterjee P; Chen H; Chen Y-C; Chhatriwalla AK; Chikowe I; Chuang T-J; Collevatti RG; Valera-Cornejo DA; Cuenda A; Dao M; Dauga D; Deng Z; Devkota K; Doan LV; Elewa YHA; Fan D; Faruk M; Feifei S; Ferguson TS; Fleres F; Foster EJ; Foster CS; Furer T; Gao Y; Garcia-Rivera EJ; Gazdar A; George RB; Ghosh S; Gianchecchi E; Gleason JM; Hackshaw A; Hall A; Hall R; Harper P; Hogg WE; Huang G; Hunter KE; IJzerman AP; Jesus C; Jian G; Lewis JSJ; Kanj SS; Kaur H; Kelly S; Kheir F; Kichatova VS; Kiyani M; Klein R; Kovesi T; Kraschnewski JL; Kumar AP; Labutin D; Lazo-Langner A; Leclercq G; Li M; Li Q; Li T; Li Y; Liao W-T; Liao Z-Y; Lin J; Lizer J; Lobreglio G; Lowies C; Lu C; Majeed H; Martin A; Martinez-Sobrido L; Meresh E; Middelveen M; Mohebbi A; Mota J; Mozaheb Z; Muyaya L; Nandhakumar A; Ng SHX; Obeidat M; Oh D-H; Owais M; Pace-Asciak P; Panwar A; Park C; Patterson C; Penagos-Tabaree F; Pianosi PT; Pinzi V; Pridans C; Psaroulaki A; Pujala RK; Pulido-Arjona L; Qi P-F; Rahman P; Rai NK; Rassaf T; Refardt J; Ricciardi W; Riess O; Rovas A; Sacks FM; Saleh S; Sampson C; Schmutz A; Sepanski R; Sharma N; Singh M; Spearman P; Subramaniapillai M; Swali R; Tan CM; Tellechea JI; Thomas L-M; Tong X; Veys R; Vitriol V; Wang H-D; Wang J; Wang J; Waugh J; Webb SA; Williams BA; Workman AD; Xiang T; Xie L-X; Xu J; Xu T; Yang C; Yoon JG; Yuan CM; Zaritsky A; Zhang Y; Zhao H; Zuckerman H; Lyu R; Pullan W; Zhou Y
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2019;5(1):37-46
ESC Council on hypertension position document on themanagement of hypertensive emergencies
van den Born B-JH; Lip GYH; Brguljan-Hitij J; Cremer A; Segura J; Morales E; Mahfoud F; Amraoui F; Persu A; Kahan T; Rosei EA; de Simone G; Gosse P; Williams B
Article: BMJ OPEN. 2018;8(12):e021038
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol
Parati G; Agabiti-Rosei E; Bakris GL; Bilo G; Branzi G; Cecchi F; Chrostowska M; De la Sierra A; Domenech M; Dorobantu M; Faria T; Huo Y; Jelakovic B; Kahan T; Konradi A; Laurent S; Li N; Madan K; Mancia G; McManus RJ; Amedeo Modesti P; Eugenio Ochoa J; Andres Octavio J; Omboni S; Palatini P; Park JB; Pellegrini D; Perl S; Podoleanu C; Pucci G; Redon J; Renna N; Rhee MY; Rodilla Sala E; Sanchez R; Schmieder R; Soranna D; Stergiou G; Stojanovic M; Tsioufis K; Grazia Valsecchi M; Veglio F; Dario Waisman G; Wang JG; Wijnmaalen P; Zambon A; Zanchetti A; Zhang Y
Article: BLOOD PRESSURE. 2018;27(6):314-340
2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
Williams B; Mancia G; Spiering W; Rosei EA; Azizi M; Burnier M; Clement D; Coca A; De Simone G; Dominiczak A; Kahan T; Mahfoud F; Redon J; Ruilope L; Zanchetti A; Kerins M; Kjeldsen S; Kreutz R; Laurent S; Lip GYH; McManus R; Narkiewicz K; Ruschitzka F; Schmieder R; Shlyakhto E; Tsioufis K; Aboyans V; Desormais I
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2018;122(1):102-107
Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD])
Mourtzinis G; Kahan T; Bostrom KB; Schioler L; Wallin LC; Hjerpe P; Hasselstrom J; Manhem K
Article: HYPERTENSION. 2018;71(4):540-547
Management of a Pregnant Woman With Fibromuscular Dysplasia
Berra E; Dominiczak AF; Touyz RM; Pierard S; Hammer F; Rossi GP; Gabriel Micali R; Staessen JA; Bursztyn M; Kahan T; Persu A
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2018;71(4):240-247
Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension
Ekholm M; Jekell A; Wallen NH; Gigante B; Kahan T
Article: JOURNAL OF HYPERTENSION. 2018;36(4):857-866
Cardiac function, myocardial mechano-energetic efficiency, and ventricular-arterial coupling in normal pregnancy
Iacobaeus C; Andolf E; Thorsell M; Bremme K; Ostlund E; Kahan T
Article: BLOOD PRESSURE. 2018;27(2):88-98
The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril Study
Jekell A; Kahan T
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(3):315-321
Drug adherence in treatment resistant and in controlled hypertensionResults from the Swedish Primary Care Cardiovascular Database (SPCCD)
Holmqvist L; Bostrom KB; Kahan T; Schioler L; Qvarnstrom M; Wettermark B; Hjerpe P; Hasselstrom J; Manhem K
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2018;51(3):361-367
Pregnancy-associated plasma protein-A is positively correlated with first-trimester skin microvascular reactivity
Iacobaeus C; Kahan T; Jorneskog G; Bremme K; Andolf E; Thorsell M
Article: JOURNAL OF HYPERTENSION. 2018;36(2):402-409
Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD)
Holmqvist L; Bostrom KB; Kahan T; Schioler L; Hasselstrom J; Hjerpe P; Wettermark B; Manhem K
Article: JOURNAL OF CLINICAL HYPERTENSION. 2018;20(1):106-114
Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity
Wallentin F; Wettermark B; Kahan T
Article: JOURNAL OF HYPERTENSION. 2018;36(1):151-158
Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation
Volz S; Spaak J; Elf J; Jagren C; Lundin C; Stenborg A; Andersson J; Rundqvist B; Kahan T; Andersson B
Article: JOURNAL OF HYPERTENSION. 2017;35(10):2102-2108
Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database
Holmquist C; Hasselstrom J; Bostrom KB; Manhem K; Wettermark B; Hjerpe P; Kahan T
Article: BLOOD PRESSURE. 2017;26(5):294-302
The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study
Gordin D; Elmula FEMF; Andersson B; Gottsater A; Elf J; Kahan T; Christensen KL; Vikatmaa P; Vikatmaa L; Olesen TB; Groop P-H; Olsen MH; Tikkanen I
Article: JOURNAL OF HYPERTENSION. 2017;35(9):1727-1741
Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension
Perrone-Filardi P; Coca A; Galderisi M; Paolillo S; Alpendurada F; de Simone G; Donal E; Kahan T; Mancia G; Redon J; Schmieder R; Williams B; Agabiti-Rosei E
Article: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING. 2017;18(9):945-960
Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients
Perrone-Filardi P; Coca A; Galderisi M; Paolillo S; Alpendurada F; de Simone G; Donal E; Kahan T; Mancia G; Redon J; Schmieder R; Williams B; Agabiti-Rosei E
Article: BLOOD PRESSURE. 2017;26(4):220-228
Non-steroidal anti-inflammatory drugs and blood pressure control in patients treated for hypertension: results from the Swedish primary care cardiovascular database
Ljungman C; Kahan T; Schioler L; Wettermark B; Bostrom KB; Hasselstrom J; Hjerpe P; Manhem K
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2017;24(11):1206-1211
Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD)
Mourtzinis G; Schioler L; Kahan T; Bostrom KB; Hjerpe P; Hasselstrom J; Manhem K
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2017;119(12):2042-2048
Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction
Lofsjogard J; Kahan T; Diez J; Lopez B; Gonzalez A; Ravassa S; Mejhert M; Edner M; Persson H
Article: EUROPACE. 2017;19(6):891-911
Hypertension and cardiac arrhythmias: a consensus document fromthe European Heart RhythmAssociation (EHRA) and ESC Council on Hypertension, endorsed by the Heart RhythmSociety (HRS), Asia-Pacific Heart RhythmSociety (APHRS) and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lip GYH; Coca A; Kahan T; Boriani G; Manolis AS; Olsen MH; Oto A; Potpara TS; Steffel J; Marin F; de Oliveira Figueiredo MJ; de Simone G; Tzou WS; Chiang C-E; Williams B; Dan G-A; Gorenek B; Fauchier L; Savelieva I; Hatala R; van Gelder I; Brguljan-Hitij J; Erdine S; Lovic D; Kim Y-H; Salinas-Arce J; Field M
Article: HEART AND VESSELS. 2017;32(6):674-684
The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study
Jekell A; Kalani M; Kahan T
Article: JOURNAL OF HYPERTENSION. 2017;35(1):188-197
Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish Primary Care Cardiovascular Database
Bokrantz T; Ljungman C; Kahan T; Bostrom KB; Hasselstrom J; Hjerpe P; Mellstrom D; Schioler L; Manhem K
Article: JOURNAL OF HYPERTENSION. 2016;34(11):2187-2198
Hypertension types defined by clinic and ambulatory blood pressure in 14143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study
Omboni S; Aristizabal D; De la Sierra A; Dolan E; Head G; Kahan T; Kantola I; Kario K; Kawecka-Jaszcz K; Malan L; Narkiewicz K; Octavio JA; Ohkubo T; Palatini P; Siegelova J; Silva E; Stergiou G; Zhang Y; Mancia G; Parati G
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2016;10(11):838-846
Prevalence of treatment-resistant hypertension and important associated factors-results from the Swedish Primary Care Cardiovascular Database
Holmqvist L; Bostrom KB; Kahan T; Schioler L; Hasselstrom J; Hjerpe P; Wettermark B; Manhem K
Article: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2016;48(4):483-490
Fetal growth is associated with first-trimester maternal vascular function
Iacobaeus C; Kahan T; Jorneskog G; Bremme K; Thorsell M; Andolf E
Article: MEDICINE. 2016;95(40):e4908
Persistence to antihypertensive drug classes: A cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD)
Qvarnstrom M; Kahan T; Kieler H; Brandt L; Hasselstrom J; Bostrom KB; Manhem K; Hjerpe P; Wettermark B
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2016;72(8):965-975
How to best assess quality of drug treatment in patients with heart failure
Zarrinkoub R; Kahan T; Johansson S-E; Wandell P; Mejhert M; Wettermark B
Article: CARDIOVASCULAR DIABETOLOGY. 2016;15:66
Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome
Papadogeorgos NO; Jorneskog G; Bengtsson M; Kahan T; Kalani M
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2016;10(4):297-306
Cardiac structure and function, and ventricular-arterial interaction 11 years following a pregnancy with preeclampsia
Al-Nashi M; Eriksson MJ; Ostlund E; Bremme K; Kahan T
Article: BLOOD COAGULATION & FIBRINOLYSIS. 2016;27(1):113-116
Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia
Ekholm M; Kahan T; Joerneskog G; Broeijersen A; Wallen NH
Article: LAKARTIDNINGEN. 2015;112:DT9A
[More rigorous blood pressure control yields results in high risk patients. American SPRINT provides increased evidence of the benefits of prevention].
Gottsäter A; Kahan T; Nilsson P
Article: JOURNAL OF HUMAN HYPERTENSION. 2015;29(6):385-393
Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD)
Ljungman C; Kahan T; Schioler L; Hjerpe P; Wettermark B; Bostrom KB; Manhem K
Article: VALUE IN HEALTH. 2015;18(4):439-448
Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry
Berg J; Lindgren P; Mejhert M; Edner M; Dahlstrom U; Kahan T
Article: JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. 2015;16(2):328-338
Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion
Ekholm M; Kahan T; Jorneskog G; Brinck J; Wallen NH
Article: BMC NEUROLOGY. 2015;15:67
Elevated blood lipids are uncommon in patients with post-polio syndrome - a cross sectional study
Melin E; Kahan T; Borg K
Article: EUROPEAN JOURNAL OF GENERAL PRACTICE. 2015;21(1):26-32
A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology
Mejhert M; Kahan T
Article: JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION. 2014;8(12):882-890
Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD)
Ljungman C; Kahan T; Schioler L; Hjerpe P; Hasselstrom J; Wettermark B; Bostrom KB; Manhem K
Article: JOURNAL OF HYPERTENSION. 2014;32(12):2422-2427
Hyperresponders vs. nonresponder patients after renal denervation: do they differ?
Persu A; Azizi M; Jin Y; Volz S; Rosa J; Elmula FEMF; Pechere-Bertschi A; Burnier M; Mark PB; Elvan A; Renkin J; Sapoval M; Kahan T; Kjeldsen S; Staessen JA
Article: SCANDINAVIAN CARDIOVASCULAR JOURNAL. 2014;48(5):299-303
Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure
Lofsjogard J; Persson H; Diez J; Lopez B; Gonzalez A; Edner M; Mejhert M; Kahan T
Article: JOURNAL OF CARDIOVASCULAR MEDICINE. 2014;15(6):463-469
Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure
Lofsjogard J; Kahan T; Diez J; Lopez B; Gonzalez A; Edner M; Henriksson P; Mejhert M; Persson H
Article: HYPERTENSION. 2014;63(6):1319-1325
Eligibility for Renal Denervation Experience at 11 European Expert Centers
Persu A; Jin Y; Baelen M; Vink E; Verloop WL; Schmidt B; Blicher MK; Severino F; Wuerzner G; Taylor A; Pechere-Bertschi A; Jokhaji F; Elmula FMFE; Rosa J; Czarnecka D; Ehret G; Kahan T; Renkin J; Widimsky JJ; Jacobs L; Spiering W; Burnier M; Mark PB; Menne J; Olsen MH; Blankestijn PJ; Kjeldsen S; Bots ML; Staessen JA
Article: BLOOD PRESSURE. 2014;23(2):116-125
The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients
Hasselstrom J; Zarrinkoub R; Holmquist C; Hjerpe P; Ljungman C; Qvarnstrom M; Wettermark B; Manhem K; Kahan T; Bostrom KB
Article: JOURNAL OF HUMAN HYPERTENSION. 2014;28(3):150-156
Blood pressure changes after renal denervation at 10 European expert centers
Persu A; Jin Y; Azizi M; Baelen M; Volz S; Elvan A; Severino F; Rosa J; Adiyaman A; Elmula FEF; Taylor A; Pechere-Bertschi A; Wuerzner G; Jokhaji F; Kahan T; Renkin J; Monge M; Widimsky P; Jacobs L; Burnier M; Mark PB; Kjeldsen SE; Andersson B; Sapoval M; Staessen JA
Article: JRSM CARDIOVASCULAR DISEASE. 2014;3:2048004014548735
Health-related quality of life and long-term morbidity and mortality in patients hospitalised with systolic heart failure
Berg J; Lindgren P; Kahan T; Schill O; Persson H; Edner M; Mejhert M
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2013;62(6):559-566
Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment: Results From the SILVHIA Study
Jekell A; Malmqvist K; Wallen NH; Mortsell D; Kahan T
Article: HYPERTENSION RESEARCH. 2013;36(12):1081-1087
Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia
Ostlund E; Al-Nashi M; Hamad RR; Larsson A; Eriksson M; Bremme K; Kahan T
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(11):1955-1964
Persistence to antihypertensive drug treatment in Swedish primary healthcare
Qvarnstrom M; Kahan T; Kieler H; Brandt L; Hasselstrom J; Bostrom KB; Manhem K; Hjerpe P; Wettermark B
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2013;168(2):789-794
Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: an analysis of the ASSOCIATE study
Tardif J-C; Ponikowski P; Kahan T
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2013;15(9):995-1002
The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden
Zarrinkoub R; Wettermark B; Wandell P; Mejhert M; Szulkin R; Ljunggren G; Kahan T
Article: JOURNAL OF HYPERTENSION. 2013;31(8):1676-1682
Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension
Schwieler JH; Kahan T; Wallen NH; Nussberger J; Hjemdahl P
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2013;41(6):637-643
Large differences between patients with acute myocardial infarction included in two Swedish health registers
Aspberg S; Stenestrand U; Koster M; Kahan T
Article: JOURNAL OF HYPERTENSION. 2013;31(7):1281-1357
2013 ESH/ESC Guidelines for themanagement of arterial hypertension The Task Force for the management ofarterial hypertension of the European Society ofHypertension (ESH) and of the European Society of Cardiology (ESC)
Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Boehm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Fagard DH; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Ryden L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Article: LAKARTIDNINGEN. 2013;110(22):1088-1089
[Hypertension is the greatest threat to global health. Increases the risk of cardiovascular disease, dementia and kidney disease].
Kahan T; Carlberg B; Nilsson PM
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2013;24(3):260-265
Long term health care consumption and cost expenditure in systolic heart failure
Mejhert M; Lindgren P; Schill O; Edner M; Persson H; Kahan T
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2013;43(2):141-151
Risk prediction in stable angina pectoris
Kahan T; Forslund L; Held C; Bjorkander I; Billing E; Eriksson SV; Nasman P; Rehnqvist N; Hjemdahl P
Article: LAKARTIDNINGEN. 2013;110(3):76
[Resistant hypertension: new perspectives for difficult-to-treat group].
Kahan T
Article: PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH. 2012;2(3):261-262
PP037. Family history of cardiovascular disease and maternal vascular function during early pregnancy.
Iacobaeus C; Jörneskog G; Kahan T; Thorsell M; Andolf E
Article: PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH. 2012;2(3):223
OS083. Fetal growth and maternal vascular function in early pregnancy.
Iacobaeus C; Jörneskog G; Kahan T; Thorsell M; Andolf E
Article: JOURNAL OF HUMAN HYPERTENSION. 2011;25(8):484-491
Antihypertensive treatment and control in a large primary care population of 21 167 patients Results from the Swedish Primary Care Cardiovascular Database (SPCCD)
Qvarnstrom M; Wettermark B; Ljungman C; Zarrinkoub R; Hasselstrom J; Manhem K; Sundstrom A; Kahan T
Article: CEREBROVASCULAR DISEASES EXTRA. 2011;1(1):66-74
A Randomized Controlled Trial on Very Early Speech and Language Therapy in Acute Stroke Patients with Aphasia
Laska AC; Kahan T; Hellblom A; Murray V; von Arbin M
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE. 2010;64(9):1228-1234
The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial
Lindgren P; Eriksson J; Buxton M; Kahan T; Poulter NR; Dahlof B; Sever PS; Wedel H; Jonsson B
Article: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2010;21(4):e733-e739
Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma
Aspberg S; Dahlquist G; Kahan T; Kallen B
Article: BLOOD PRESSURE. 2010;19(3):176-181
Cardiovascular risk factors are not treated to target in hypertensive patients in primary care
Nieburg I; Kahan T
Article: HEALTH POLICY. 2010;94(3):221-229
Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
Wettermark B; Godman B; Neovius M; Hedberg N; Mellgren T-O; Kahan T
Article: LAKARTIDNINGEN. 2009;106(32-33):1992-1994
[SBU should investigate what is an evidence-based and cost-effective use of statins].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B
Article: ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES. 2009;26(7):753-758
The Effects of Antihypertensive Treatment on the Doppler-Derived Myocardial Performance Index in Patients with Hypertensive Left Ventricular Hypertrophy: Results from the Swedish Irbesartan in Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)
Liljedahl S; Kahan T; Lind L; Arnlov J
Article: LAKARTIDNINGEN. 2009;106(20):1349-1350
[Correctly measured blood pressure, thanks!].
Kahan T
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2009;29(3):201-208
Long-term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction
Bjorkander I; Forslund L; Ericson M; Rehnqvist N; Hjemdahl P; Kahan T
Article: THROMBOSIS RESEARCH. 2009;124(1):110-115
Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo
Ekholm M; Kahan T; Jorneskog G; Broijersen A; Wallen NH
Article: EUROPEAN HEART JOURNAL. 2009;30(5):540-548
Efficacy of the I_f current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial
Tardif J-C; Ponikowski P; Kahan T
Article: PHARMACOECONOMICS. 2009;27(3):221-230
The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone Results from ASCOT
Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlof B; Sever PS; Wedel H; Jonsson B
Article: JOURNAL OF CARDIOVASCULAR MEDICINE. 2008;9(10):1037-1044
Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia
Jorneskog G; Kahan T; Ekholm M; Broijersen A; Wallen NH
Article: AMERICAN JOURNAL OF HYPERTENSION. 2008;21(7):836-839
The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism:: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) trial
Kurland L; Hallberg P; Melhus H; Liljedahl U; Hashemi N; Syvanen A-C; Lind L; Kahan T
Article: TOPICS IN STROKE REHABILITATION. 2008;15(3):256-261
Design and methods of a randomized controlled trial on early speech and language therapy in patients with acute stroke and aphasia
Laska AC; Kahan T; Hellblom A; Murray V; von Arbin M
Article: JOURNAL OF WOMENS HEALTH. 2008;17(3):373-381
Sex differences in systolic heart failure in the elderly: The prognostic importance of left ventricular mass in women
Mejhert M; Kahan T; Edner M; Persson HE
Article: CARDIOLOGY. 2008;111(2):126-133
Differential index:: A simple time domain heart rate variability analysis with prognostic implications in stable angina pectoris
Bjoerkander I; Forslund L; Kahan T; Ericson M; Held C; Rehnqvist N; Hjemdahl P
Article: JOURNAL OF HUMAN HYPERTENSION. 2007;21(12):956-965
Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol: results from the SILVHIA study
Malmqvist K; Kahan T; Edner M; Bergfeldt L
Article: JOURNAL OF HYPERTENSION. 2007;25(9):1958-1966
Myocardial fibrosis and diastolic dysfunction in patients with hypertension:: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
Muller-Brunotte R; Kahan T; Lopez B; Edner M; Gonzalez A; Diez J; Malmqvista K
Article: PEDIATRIC ALLERGY AND IMMUNOLOGY. 2007;18(4):313-319
Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?
Aspberg S; Dahlquist G; Kahan T; Kaellen B
Article: JOURNAL OF REHABILITATION MEDICINE. 2007;39(5):387-392
Clinical and prognostic properties of standardized and functional aphasia assessments
Laska AC; Bartfai A; Hellblom A; Murray V; Kahan T
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(5):472-479
Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol:: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study
Mortsell D; Malmqvist K; Held C; Kahan T
Article: EUROPEAN JOURNAL OF HEALTH ECONOMICS. 2007;8(1):25-30
Utility loss and indirect costs following cardiovascular events in hypertensive patients:: the ASCOT health economic substudy
Lindgren P; Kahan T; Poulter N; Buxton M; Svarvar P; Dahlof B; Jonsson B
Article: JOURNAL OF INTERNAL MEDICINE. 2007;261(2):148-158
Mechanisms of exercise-induced ST-segment depression in patients without typical angina pectoris
Sundkvist GMG; Hjemdahl P; Kahan T; Melcher A
Article: CEREBROVASCULAR DISEASES. 2007;24(1):74-79
Recognition of depression in aphasic stroke patients
Laska AC; Martensson B; Kahan T; von Arbin M; Murray V
Article: JOURNAL OF HYPERTENSION. 2007;25(1):169-175
Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity
Lindqvist M; Kahan T; Melcher A; Ekholm M; Hjemdahl P
Article: AMERICAN JOURNAL OF HYPERTENSION. 2006;19(9):927-936
Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy -: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)
Muller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Article: ACTA PAEDIATRICA. 2006;95(8):1001-1004
Fetal and perinatal risk factors for inflammatory bowel disease
Aspberg S; Dahlquist G; Kahan T; Kallen B
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2006;109(1):108-113
Predicting readmissions and cardiovascular events in heart failure patients
Mejhert M; Kahan T; Persson H; Edner M
Article: JOURNAL OF INTERNAL MEDICINE. 2005;257(6):514-522
Nurse-recorded clinic and ambulatory blood pressures correlate equally well with left ventricular mass and carotid intima-media thickness
Nyström F; Malmqvist K; Lind L; Kahan T
Article: JOURNAL OF HYPERTENSION. 2005;23(3):633-640
Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy
Müller-Brunotte R; Edner M; Malmqvist K; Kahan T
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2005;98(3):493-499
Differential index, a novel graphical method for measurements of heart rate variability
Björkander I; Kahan T; Ericson M; Held C; Forslund L; Rehnqvist N; Hjemdahl P
Article: JOURNAL OF CARDIOVASCULAR RISK. 2005;12(1):29-36
Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm (ASCOT-LLA)
Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlöf B; Sever PS; Wedel H; Jönsson B
Article: HEART. 2005;91(2):250-256
Left ventricular hypertrophy in hypertension: Its arrhythmogenic potential
Kahan T; Bergfeldt L
Article: CEREBROVASCULAR DISEASES. 2005;19(2):125-132
Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: A randomised, double-blind, placebo-controlled study
Laska AC; von Arbin M; Kahan T; Hellblom A; Murray V
Article: JOURNAL OF HYPERTENSION. 2004;22(12):2321-2328
Single nucleotide polymorphisms predict the change in left ventricular mass in response to anti hypertensive treatment
Liljedahl U; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L; Kurland L
Article: BMC CARDIOVASCULAR DISORDERS. 2004;4(1):16
Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment.
Liljedahl U; Lind L; Kurland L; Berglund L; Kahan T; Syvänen A-C
Article: HEART. 2004;90(9):1010-1015
Limited long term effects of a management programme for heart failure
Mejhert M; Kahan T; Persson H; Edner M
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2004;96(2):183-189
Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction?
Quintana M; Edner M; Kahan T; Hjemdahl P; Sollevi A; Rehnqvist N
Article: CLINICAL CARDIOLOGY. 2004;27(6):347-350
Beta₁-adrenergic receptor gene polymorphisms and response to betal₁-adrenergic receptor blockade in patients with essential hypertension
Karlsson J; Lind L; Hallberg P; Michaëlsson K; Kurland L; Kahan T; Malmqvist K; Öhman KP; Nyström E; Melhus H
Article: CLINICAL CARDIOLOGY. 2004;27(5):287-290
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment - Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)
Hallberg P; Karlsson J; Lind L; Michaëlsson K; Kurland L; Kahan T; Malmqvist K; Öhman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
Article: CLINICAL CARDIOLOGY. 2004;27(3):169-173
Transforming growth factor β1 genotype and change in left ventricular mass during antihypertensive treatment -: Results from the Swedish Irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA)
Hallberg P; Lind L; Billberger K; Michaelsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Öhman KP; Nyström F; Liljedahl U; Syvänen AC; Melhus H
Article: CORONARY ARTERY DISEASE. 2004;15(1):31-37
Spinal cord stimulation for refractory angina pectoris: a retrospective analysis of efficacy and cost-benefit
Yu W; Maru F; Edner M; Hellström K; Kahan T; Persson H
Article: BLOOD PRESSURE. 2004;13(3):152-157
A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA)
Brändström H; Stiger F; Kahan T; Melhus H; Nyström F; Öhman KP; Malmqvist K; Lind L; Kindmark A
Article: AMERICAN JOURNAL OF HYPERTENSION. 2004;17(1):8-13
Angiotensinogen gene polymorphisms: Relationship to blood pressure response to antihypertensive treatment
Kurland L; Liljedahl U; Karlsson J; Kahan T; Malmqvist K; Melhus H; Syvänen AC; Lind L
Article: JOURNAL OF HUMAN HYPERTENSION. 2003;17(12):841-849
Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy
Müller-Brunotte R; Kahan T; Malmqvist K; Edner M
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 2003;42(6):719-726
Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension - The Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)
Malmqvist K; Öhman KP; Lind L; Nyström F; Kahan T
Article: BMC CARDIOVASCULAR DISORDERS. 2003;3:11
Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy
Hallberg P; Lind L; Michaelsson K; Kurland L; Kahan T; Malmqvist K; Ohman KP; Nystrom F; Liljedahl U; Syvanen A-C; Melhus H
Article: LAKARTIDNINGEN. 2003;100(21):1919-1920
[The Swedish Society of Hypertension: cooperation with industry is desirable and necessary--with integrity preserved].
Nilsson P; Hedner T; Himmelmann A; Kahan T; Manhem K; Norrvinsdotter-Borg I; Nyström F; Svensson P; Wallén T
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2003;59(1):1-9
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis - Results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study
Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Kjerr ESAC; Näsman P
Article: JOURNAL OF HYPERTENSION. 2003;21(3):621-624
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial
Hallberg P; Lind L; Michaëlsson K; Karlsson J; Kurland L; Kahan T; Malmqvist K; Öhman KP; Nyström F; Melhus H
Article: PHARMACOGENETICS AND GENOMICS. 2003;13(1):7-17
A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response
Liljedahl U; Karlsson J; Melhus H; Kurland L; Lindersson M; Kahan T; Nyström F; Lind L; Syvänen AC
Article: ATHEROSCLEROSIS. 2002;165(2):271-276
Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals
Holmlund A; Hulthe J; Millgård J; Sarabi M; Kahan T; Lind L
Article: AMERICAN JOURNAL OF CARDIOLOGY. 2002;90(10):1107-1112
Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)
Malmqvist K; Kahan T; Edner M; Bergfeldt L
Article: JOURNAL OF INTERNAL MEDICINE. 2002;252(5):430-439
Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin
Malmqvist K; Öhman KP; Lind L; Nyström F; Kahan T
Article: JOURNAL OF HYPERTENSION. 2002;20(10):2089-2093
The CYP2C9 genotype predicts the blood pressure response to irbesartan:: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial
Hallberg P; Karlsson J; Kurland L; Lind L; Kahan T; Malmqvist K; Öhman KP; Nyström F; Melhus H
Article: HEART. 2002;88(3):239-243
Ventilatory variables are strong prognostic markers in elderly patients with heart failure
Mejhert M; Linder-Klingsell E; Edner M; Kahan T; Persson H
Article: JOURNAL OF HYPERTENSION. 2002;20(8):1563-1569
Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy
Malmqvist K; Wallén HN; Held C; Kahan T
Article: JOURNAL OF HYPERTENSION. 2002;20(8):1527-1533
Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension:: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study
Nyström F; Malmqvist K; Öhman KP; Kahan T
Article: CLINICAL SCIENCE. 2002;103(2):151-155
Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension
Ekholm M; Wallén NH; Johnsson H; Eliasson K; Kahan T
Article: JOURNAL OF INTERNAL MEDICINE. 2002;251(6):508-517
The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events:: a Swedish sub-study to the HOPE study
Björholt I; Andersson FL; Kahan T; Östergren J
Article: AMERICAN JOURNAL OF HYPERTENSION. 2002;15(5):389-393
Aldosterone synthase (CYP11B2)-344 C/T polymorphism is related to antihypertensive response
Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Öhman P; Nyström F; Hägg A; Lind L
Article: HEART. 2002;87(5):415-422
Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris
Forslund L; Björkander I; Ericson M; Held C; Kahan T; Rehnqvist N; Hjemdahl P
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2002;293(1):13-17
A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function
Brändström H; Stiger F; Lind L; Kahan T; Melhus H; Kindmark A
Article: JOURNAL OF HYPERTENSION. 2002;20(4):657-663
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during anti hypertensive treatment:: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial
Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Öhman P; Nyström F; Hägg A; Lind L
Article: LIPIDS. 2002;37(3):231-236
Cardiac and vascular structure and function are related to lipid peroxidation and metabolism
Steer P; Millgård J; Sarabi DM; Basu S; Vessby B; Kahan T; Edner M; Lind L
Article: JOURNAL OF CARDIOVASCULAR RISK. 2002;9(1):53-57
Endothelium-dependent vasodilation is impaired in apparently healthy subjects with a family history of myocardial infarction
Lind L; Sarabi M; Millgård J; Kahan T
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2002;4(1):73-82
Neurohormonal activation in heart failure after acute myocardial infarction treated with beta-receptor antagonists
Persson H; Andréasson K; Kahan T; Eriksson SV; Tidgren B; Hjemdahl P; Hall C; Erhardt L
Article: JOURNAL OF HYPERTENSION. 2001;19(10):1813-1818
Treatment with irbesartan or atenolol improves endothelial function in essential hypertension
zur Mühlen BV; Kahan T; Hägg A; Millgård J; Lind L
Article: JOURNAL OF HYPERTENSION. 2001;19(10):1783-1787
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients
Kurland L; Melhus H; Karlsson J; Kahan T; Malmqvist K; Öhman KP; Nyström F; Hägg A; Lind L
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15:S91-S93
The effects of cardiac events on quality of life and indirect costs
Jönsson B; Buxton M; Kahan T; Poulter NR; Svarvar P
Article: JOURNAL OF HUMAN HYPERTENSION. 2001;15:S53-S56
Health economics of prevention of coronary heart disease and vascular events:: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Jönsson B; Buxton M; Hertzman P; Kahan T; Poulter N
Article: JOURNAL OF HYPERTENSION. 2001;19(6):1167-1176
Regression of left ventricular hypertrophy in human hypertension with irbesartan
Malmqvist K; Kahan T; Edner M; Held C; Hägg A; Lind L; Müller-Brunotte R; Nyström F; Öhman KP; Osbakken MD; Östergren J
Article: JOURNAL OF INTERNAL MEDICINE. 2001;249(5):413-422
Aphasia in acute stroke and relation to outcome
Laska AC; Hellblom A; Murray V; Kahan T; Von Arbin M
Article: JOURNAL OF CARDIOVASCULAR RISK. 2001;8(2):73-80
Risk factors in established coronary heart disease: evaluation of a secondary prevention programme
Kahan T; Wändell P
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 2001;21(2):196-207
Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes
Malmqvist K; Kahan T; Eriksson S; Björkander I; Held C; Forslund L; Rehnqvist N; Hjemdahl P
Article: JOURNAL OF HYPERTENSION. 2001;19(2):311-317
Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension
Malmqvist K; Isaksson H; Östergren J; Kahan T
Article: BLOOD PRESSURE. 2001;10(2):101-110
Regression of left ventricular mass with captopril and metoprolol, and the effects on glucose and lipid metabolism
Malmqvist K; Kahan T; Isaksson H; Östergren J
Article: EUROPEAN JOURNAL OF HEART FAILURE. 2001;3(1):69-78
Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double-blind, randomized, placebo-controlled multicentre study
Sigurdsson A; Eriksson SV; Hall C; Kahan T; Swedberg K
Article: CORONARY ARTERY DISEASE. 2000;11(7):523-526
Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction
Kahan T; Lundman P; Olsson G; Wendt M
Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(2):159-164
Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 1987-95.: Results from the National AMI Register in Sweden
Rosén M; Alfredsson L; Hammar N; Kahan T; Spetz CL; Ysberg AS
Article: EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY. 2000;1(2):87-95
Influence of age and cardiovascular factors on regional pulsed wave Doppler myocardial imaging indices.
Edner M; Jarnert C; Müller-Brunotte R; Malmqvist K; Ring M; Kjerr AC; Lind L; Kahan T
Article: AMERICAN JOURNAL OF HYPERTENSION. 2000;13(5):504-511
Angiotensin II type 1 (AT₁) receptor blockade in hypertensive women: Benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide
Malmqvist K; Kahan T; Dahl M
Article: BLOOD PRESSURE. 2000;9(6):309-314
Left ventricular hypertrophy is associated with an attenuated endothelium dependent vasodilation in hypertensive men
Millgård J; Hägg A; Kahan T; Landelius J; Malmqvist K; Sarabi M; Lind L
Article: AMERICAN JOURNAL OF HYPERTENSION. 1999;12(12):1188-1194
The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension
Kahan T; Eliasson K
Article: CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING. 1999;19(5):400-409
Endothelium-dependent vasodilation and structural and functional changes in the cardiovascular system are dependent on age in healthy subjects
Lind L; Sarabi M; Millgård J; Kahan T; Edner M
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1999;34(2):268-274
Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans
Schwieler JH; Ericsson H; Löfdahl P; Thulin T; Kahan T
Article: BLOOD PRESSURE. 1999;8(3):158-164
Endothelium-dependent vasodilatation in treated and untreated hypertensive subjects
Lind L; Millgård J; Sarabi M; Kahan T; Malmqvist K; Hägg A
Article: JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. 1998;32(5):753-759
Adrenaline responsiveness in mild hypertension: No evidence for altered β-adrenoceptor sensitivity
Kahan T; Hjemdahl P; Lindvall K; Östergren J; de Faire U
Article: ACTA PHYSIOLOGICA. 1997;159(2):107-111
Plasma angiotensins and human forearm circulation: Effects of sympatho-adrenal activation
Kahan T; Lindqvist M; Nussberger J; Melcher A; Hjemdahl P
Article: LAKARTIDNINGEN. 1996;93(42):3697-3700
[A model for study of quality of myocardial infarction care. Distinct targets improve the care].
Forslund L; Kahan T; Nilsson R; Norhagen PH; Adamson U
Article: HAEMOSTASIS. 1996;26(5):247-257
Anticoagulant effects of low-molecular-weight heparin following thrombolytic therapy in acute myocardial infarction: A dose-finding study
Strandberg LE; Kahan T; Lundin P; Svensson J; Erhardt L
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1996;270(3):E393-E399
Forearm vasodilator mechanisms during mental stress: Possible roles of epinephrine and ANP
Lindqvist M; Kahan T; Melcher A; Bie P; Hjemdahl P
Show more

All other publications

Corrigendum: JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION. 2025;32(1):261-263
Are medical history data fit for risk stratification of patients with chest pain in emergency care? Comparing data collected from patients using computerized history taking with data documented by physicians in the electronic health record in the CLEOS-CPDS prospective cohort study (vol 31, pg 1529, 2024)
Brandberg H; Sundberg CJ; Spaak J; Koch S; Kahan T
Other: BLOOD PRESSURE. 2024;33(1):2317263
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?
Kreutz R; Azizi M; Grassi G; Januszewicz A; Kahan T; Lurbe E; Polonia J; Tsioufis K; Weber T; Williams B; Mancia G
Editorial comment: EUROPEAN HEART JOURNAL OPEN. 2024;5(1):oeaf015
Intervention, improved prevention, imaging, inflammation, and innovation: the five I's cardiovascular highlights in EHJ Open 2024
Back M; Banach M; Braunschweig F; De Rosa S; Flachskampf FA; Kahan T; Ketelhuth DFJ; Lancellotti P; Larsson SC; Mellbin L; Savarese G; Jensen AS; Szummer K; Wahl D
Editorial comment: EUROPEAN HEART JOURNAL OPEN. 2022;2(6):oeac084
Highlights from 2022 in EHJ Open
Back M; Banach M; Braunschweig F; De Rosa S; Gimelli A; Kahan T; Ketelhuth DFJ; Lancellotti P; Larsson SC; Mellbin L; Nagy E; Savarese G; Szummer K; Wahl D
Conference publication: JOURNAL OF HYPERTENSION. 2022;40(SUPPL):E9
BLOOD PRESSURE IN ATRIAL FIBRILLATION AND IN SINUS RHYTHM DURING 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING: DATA FROM THE TEMPLAR PROJECT
Lundwall K; Kahan T; Omboni S
Editorial comment: POLISH HEART JOURNAL-KARDIOLOGIA POLSKA. 2022;80(3):350-352
Does sodium and potassium intake assessment by diet-related mobile applications do more harm than good?
Sobieraj P; Bzikowska-Jura A; Raciborski F; Kucharska A; Szostak-Wegierek D; Kahan T
Review: VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE. 2021;50(6):401-411
Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease
Belch JJF; Brodmann M; Baumgartner I; Binder CJ; Casula M; Heiss C; Kahan T; Parini P; Poredos P; Catapano AL; Tokgozoglu L
Editorial comment: LANCET. 2021;398(10305):1022-1023
Low-dose combination of blood pressure-lowering medicines
Kahan T
Review: EUROPEAN HEART JOURNAL. 2021;42(35):3427-3520
2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)
Glikson M; Nielsen JC; Kronborg MB; Michowitz Y; Auricchio A; Barbash IM; Barrabes JA; Boriani G; Braunschweig F; Brignole M; Burri H; Coats AJS; Deharo J-C; Delgado V; Diller G-P; Israel CW; Keren A; Knops RE; Kotecha D; Leclercq C; Merkely B; Starck C; Thylen I; Maria Tolosana J
Review: FRONTIERS IN PHARMACOLOGY. 2021;12:640185
The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
Ekholm M; Kahan T
Editorial comment: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2021;7(3):242-250
Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Mancusi C; de Simone G; Hitij JB; Sudano I; Mahfoud F; Parati G; Kahan T; Barbato E; Pierard LA; Garbi M; Flachskampf FA; Gerdts E
Editorial comment: LANCET. 2021;397(10285):1598-1599
Decisions about antihypertensive treatment should focus on reducing cardiovascular risk
Kahan T
Review: LAKARTIDNINGEN. 2020;117:20102
[Hypertension, RAAS blockade and risk in COVID-19 patients].
Spaak J; Kahan T
Editorial comment: LANCET. 2019;394(10199):615-617
Strategies to identify patients for antihypertensive treatment
Kahan T
Review: CURRENT PHARMACEUTICAL DESIGN. 2019;24(37):4391-4396
Treatment of Hypertensive Left Ventricular Hypertrophy
Jekell A; Nilsson PM; Kahan T
Letter: JOURNAL OF HYPERTENSION. 2019;37(2):449-451
Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation Reply
Volz S; Spaak J; Rundqvist B; Kahan T; Andersson B
Letter: JOURNAL OF HYPERTENSION. 2018;36(8):1770-1771
Cardiac function in pregnancy Reply
Iacobaeus C; Andolf E; Thorsell M; Bremme K; Ostlund E; Kahan T
Review: PHARMACOECONOMICS. 2018;36(2):205-213
Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe
Hermansson J; Kahan T
Review: JOURNAL OF HYPERTENSION. 2018;36(2):221-229
Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis
Persu A; Gordin D; Jacobs L; Thijs L; Bots ML; Spiering W; Miroslawska A; Spaak J; Rosa J; de Jong MR; Berra E; Elmula FEMF; Wuerzner G; Taylor AHM; Olszanecka A; Czarnecka D; Mark PB; Burnier M; Renkin J; Kjeldsen SE; Widimsky J; Elvan A; Kahan T; Steigen TK; Blankestijn PJ; Tikkanen I; Staessen JA
Review: EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY. 2017;3(4):235-250
Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lip GYH; Coca A; Kahan T; Boriani G; Manolis AS; Olsen MH; Oto A; Potpara TS; Steffel J; Marin F; de Oliveira Figueiredo MJ; de Simone G; Tzou WS; Chiang CE; Williams B; Dan G-A; Gorenek B; Fauchier L; Savelieva I; Hatala R; van Gelder I; Brguljan-Hitij J; Erdine S; Lovic D; Kim Y-H; Salinas-Arce J; Field M
Editorial comment: LANCET. 2017;389(10085):2170-2172
Target blood pressure in patients at high cardiovascular risk
Kahan T
Editorial comment: JOURNAL OF HYPERTENSION. 2017;35(6):1168-1169
Potential of folate supplementation to reduce mortality in hypertensive patients.
Kahan T; Spaak J
Review: ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2017;49(1):46-53
Longitudinal study of vascular structure and function during normal pregnancy
Iacobaeus C; Andolf E; Thorsell M; Bremme K; Jorneskog G; Ostlund E; Kahan T
Review: EUROPEAN CARDIOLOGY. 2016;11(1):18-19
Challenges in Resistant Hypertension
Kahan T
Letter: HYPERTENSION RESEARCH. 2015;38(11):796-797
Reassessment of data on timing peak flow-mediated vasodilatation confirms that endothelial function returns to normal 11 years after preeclampsia
Kahan T; Bremme K; Ostlund E
Editorial comment: JOURNAL OF HYPERTENSION. 2015;33(7):1371-1372
Safety of digoxin use in patients with hypertensive heart disease and atrial fibrillation
Kahan T
Editorial comment: JOURNAL OF HUMAN HYPERTENSION. 2015;29(5):281-282
Renal nerve stimulation to predict responders to renal denervation.
Kahan T; Spaak J
Editorial comment: JOURNAL OF HYPERTENSION. 2015;33(4):690-692
The importance of left ventricular geometry in hypertensive heart disease
Kahan T; Persson H
Editorial comment: LANCET. 2014;383(9932):1866-1868
Focus on blood pressure as a major risk factor
Kahan T
Letter: JOURNAL OF HYPERTENSION. 2013;31(10):2103-2104
Platelet activation during exercise is not attenuated by inhibition of the renin-angiotensin system: the role of physical activity Reply
Kahan T; Schwieler JH; Wallen H; Nussberger J; Hjemdahl P
Letter: JOURNAL OF HYPERTENSION. 2013;31(9):1917
Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply
Kahan T; Schwieler JH; Wallen H; Nussberger J; Hjemdahl P
Review: EUROPEAN HEART JOURNAL. 2013;34(28):2159-2219
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Mancia G; Fagard R; Narkiewicz K; Redon J; Zanchetti A; Böhm M; Christiaens T; Cifkova R; De Backer G; Dominiczak A; Galderisi M; Grobbee DE; Jaarsma T; Kirchhof P; Kjeldsen SE; Laurent S; Manolis AJ; Nilsson PM; Ruilope LM; Schmieder RE; Sirnes PA; Sleight P; Viigimaa M; Waeber B; Zannad F; Redon J; Dominiczak A; Narkiewicz K; Nilsson PM; Burnier M; Viigimaa M; Ambrosioni E; Caufield M; Coca A; Olsen MH; Schmieder RE; Tsioufis C; van de Borne P; Zamorano JL; Achenbach S; Baumgartner H; Bax JJ; Bueno H; Dean V; Deaton C; Erol C; Fagard R; Ferrari R; Hasdai D; Hoes AW; Kirchhof P; Knuuti J; Kolh P; Lancellotti P; Linhart A; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Sirnes PA; Tamargo JL; Tendera M; Torbicki A; Wijns W; Windecker S; Clement DL; Coca A; Gillebert TC; Tendera M; Rosei EA; Ambrosioni E; Anker SD; Bauersachs J; Hitij JB; Caulfield M; De Buyzere M; De Geest S; Derumeaux GA; Erdine S; Farsang C; Funck-Brentano C; Gerc V; Germano G; Gielen S; Haller H; Hoes AW; Jordan J; Kahan T; Komajda M; Lovic D; Mahrholdt H; Olsen MH; Ostergren J; Parati G; Perk J; Polonia J; Popescu BA; Reiner Z; Rydén L; Sirenko Y; Stanton A; Struijker-Boudier H; Tsioufis C; van de Borne P; Vlachopoulos C; Volpe M; Wood DA
Editorial comment: JOURNAL OF HYPERTENSION. 2012;30(4):685-687
The importance of myocardial fibrosis in hypertensive heart disease
Kahan T
Other: LAKARTIDNINGEN. 2009;106(40):2550-2551
[Lower and lower cholesterol targets increase adverse effects].
Hjemdahl P; Allhammar A; Heaton C; Hulting J; Kahan T; Malmström R; Martinsson A; Rücker F; Schenck-Gustafsson K; Schwieler J; Törnerud M; Wettermark B; Forfattarna utgör Läkemedelssakkunnigas (Läksak) e; Stockholms Iäns landsting
Review: JOURNAL OF WOMENS HEALTH. 2009;18(7):1049-1062
Treatment of Mild to Moderate Hypertension by Gender Perspective: A Systematic Review
Ljungman C; Mortensen L; Kahan T; Manhem K
Letter: JOURNAL OF HYPERTENSION. 2008;26(7):1497-1499
Left ventricular long-axis dysfunction in hypertensive patients -: Reply
Muller-Brunotte R; Kahan T
Editorial comment: HEART. 2008;94(2):e4
Economic evaluation of ASCOT-BPLA:: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen
Lindgren P; Buxton M; Kahan T; Poulter NR; Dahlof B; Sever PS; Wedel H; Jonsson B
Review: EUROPEAN HEART JOURNAL. 2007;28(12):1462-1536
2007 Guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)
Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Struijker Boudier HAJ; Zanchetti A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Luis Zamorano J; Erdine S; Kiowski W; Agabiti-Rosei E; Ambrosioni E; Lindholm LH; Manolis A; Nilsson PM; Redon J; Struijker-Boudier HAJ; Viigimaa M; Adamopoulos S; Bertomeu V; Clement D; Farsang C; Gaita D; Lip G; Mallion J-M; Manolis AJ; O'Brien E; Ponikowski P; Ruschitzka F; Tamargo J; van Zwieten P; Waeber B; Williams B
Review: JOURNAL OF HYPERTENSION. 2007;25(6):1105-1187
2007 guidelines for the management of arterial hypertension
Mancia G; De Backer G; Dominiczak A; Cifkova R; Fagard R; Germano G; Grassi G; Heagerty AM; Kjeldsen SE; Laurent S; Narkiewicz K; Ruilope L; Rynkiewicz A; Schmieder RE; Boudier HAJS; Zanchetti A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Filippatos G; Funck-Brentano C; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Luis Zamorano J; Erdine S; Kiowski W; Agabiti-Rosei E; Ambrosioni E; Lindholm LH; Manolis A; Nilsson PM; Redon J; Struijker-Boudier HAJ; Viigimaa M; Adamopoulos S; Bertomeu V; Clement D; Farsang C; Gaita D; Lip G; Mallion J-M; Manolis AJ; O'Brien E; Ponikowski P; Ruschitzka F; Tamargo J; van Zwieten P; Waeber B; Williams B
Editorial comment: DRUGS. 2006;66(7):970
Delapril/manidipine
Kahan T
Editorial comment: DRUGS. 2006;66(7):970-971
Delapril/manidipine: viewpoints.
Kahan T; Ambrosioni E
Other: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 2005;9(4):276-279
Adenosine may not improve clinical outcomes for people with STEMI. Commentary.
Quintana M; Kahan T
Meeting abstract: AMERICAN JOURNAL OF HYPERTENSION. 2005;18(5):155A
Impaired night time reduction in blood pressure is associated with cardiac hypertrophy, increased natriuretic hormone levels and left ventricular systolic and diastolic dysfunction
Nyström FH; Malmqvist K; Lind L; Kahan T
Other: EVIDENCE-BASED CARDIOVASCULAR MEDICINE. 2005;9(1):11-13
Atenolol is less effective than other antihypertensive drugs. Commentary 1.
Kahan T
Meeting abstract: VALUE IN HEALTH. 2004;7(6):694
Cost-effectiveness of reduction in cardiovascular outcomes with atorvastatin in patients with normal to mildly elevated cholesterol levels, treated for hypertension:: The ASCOT-LLA study
Lindgren P; Buxton MJ; Kahan T; Poulter N; Dahlöf B; Sever P; Wedel H; Jönsson B
Review: AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS. 2004;4(3):159-167
Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Published conference paper: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2001;30:S30-S34
A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden
Hammar N; Alfredsson L; Rosén M; Spetz CL; Kahan T; Ysberg AS
Review: EUROPEAN JOURNAL OF HEART FAILURE. 2001;3(1):97-103
Epidemiology of heart failure in Sweden - a national survey
Mejhert M; Persson H; Edner M; Kahan T
Published conference paper: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2001;(117):19-21
Pharmaeoeconomic impact of HOPE
Östergren JB; Björholt I; Andersson F; Kahan T
Meeting abstract: JOURNAL OF HYPERTENSION. 2000;18:S165
ACE-gene polymorphism predicts blood pressure response to AT1-receptor antagonist treatment in hypertensive patients
Kurland L; Melhus H; Kahan T; Malmquist K; Öhman KP; Nyström F; Hägg A; Lind L
Published conference paper: JOURNAL OF HYPERTENSION, SUPPLEMENT. 1998;16(7):S23-S29
The importance of left ventricular hypertrophy in human hypertension
Kahan T
Meeting abstract: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1998;31:212A
Rate and extent of left ventricular hypertrophy regression: A comparison of angiotensin II blockade with irbesartan and beta-blockade
Kahan T; Malmqvist K; Edner M; Held C; Osbakken M
Show more

About me

Research

Articles

All other publications

News from KI

Events from KI